From Pharmacy Practice News, 30 December 2019

That top level of quality is critical, especially in IV compounding, added Mark Neuenschwander, the founding director of THRIV, an organization advocating for accuracy in IV medication preparation.

“The surest way for hospitals to maintain IV sterility and achieve IV accuracy” is to purchase products in ready-to-use formulations from facilities that follow Current Good Manufacturing Practices, Mr. Neuenschwander noted. But the ready-to-use route is not always sufficient to meet the steadily rising numbers of IV drugs that many hospitals need to have on hand, he said. Whether it’s advances in pharmacogenomics that call for more personalized dosing or persistent drug shortages, the volume of IV medications keeps trending up, he stressed.

Given those in-house production pressures, it’s critical for health systems “to use technologies that ensure product sterility and ingredient accuracy,” Mr. Neuenschwander said. Read full article here.